BRM4 Shown to Triple Natural Killer (NK) Cell Activity

November 17, 2008

Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC).

BRM4 ® in a 250mg dosage, 60 count bottle, has been available through physicians for over 10 years. In pre-clinical studies, the power of BRM4 ® multiplies T cell levels up to 200%. The enhanced activity of helper T cells promotes the proliferation of cytotoxic T and B cells for essential immune support. Helper T cells also signal plasma B cells when they encounter their cognate antigen to secure a health production of antibodies. Furthermore, BRM4 ® supports the body’s natural production of cytokines to control inflammatory response.(Los Angeles, CA) November 17, 2008 – Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC), has been clinically shown to triple Natural Killer (NK) cell activity, increase T and B lymphocytes and demonstrate vital antioxidant and anti-inflammatory action.                                                                                     

RBAC, a polysaccharide dietary fiber derived from rice bran, is modified by a Shiitake mushroom enzyme using a patented biotechnology process. As an immune modulator, BRM4 ® retains its effectiveness over time. Clinical trials have shown BRM4 ® is safe with no side effects. In over 12 years of worldwide use, there have been no reported cases of drug interactions. BRM4 ® is recognized as the gold standard immune product worldwide for people with seriously compromised immune systems.

Double Strength BRM4 ® is now available to health professionals in the U.S. For more product and ordering information call 877-4DHDMED (877-434-3633) or email info@dhdmed.com

Los Angeles-based Daiwa Health Development, Inc. is a subsidiary of Daiwa Pharmaceutical Co. Ltd. based in Tokyo, Japan. Daiwa has become a leading research and manufacturing company, striving to create new value in the field of bioscience. Daiwa focuses on the manufacturing and distribution of nutraceuticals, functional foods and cosmetics.
 




Leave a comment

Comments will be approved before showing up.


Also in Blog Posts

Tips for Maintaining a Healthy Heart and Circulation during the Pandemic
Tips for Maintaining a Healthy Heart and Circulation during the Pandemic

February 11, 2021

The immune system is weaker among those with heart disease so it is more difficult to combat infection. At the same time, Covid-19 may affect the cardiovascular system so those who already have preexisting heart problems can have a more severe infection.

Continue Reading

Krill Oil: The Better Choice Over Fish Oil - Part 2
Krill Oil: The Better Choice Over Fish Oil - Part 2

January 29, 2021

Omega-3 fatty acids from krill oil are better able to regulate blood lipids compared to fish oil. Studies have shown that krill oil can lead to a significant reduction in total cholesterol, LDL and triglycerides more effectively than fish oil. Regulation of blood lipids lowers the risk for cardiovascular disease.

Continue Reading

Krill Oil Basics: What You Need to Know - Part 1
Krill Oil Basics: What You Need to Know - Part 1

January 14, 2021

Krill oil and fish oil are both omega-3 fatty acid supplements. However, the DHA and EPA from krill oil are more bioavailable and are better able to reach the organs where they are needed the most: the heart, brain, eyes, and joints.

Continue Reading

*** WHAT'S NEW ***

Subscribe and SAVE 5% off on all products! 

Please be advised that due to high demand and unusual volume of BRM4 orders, we are limiting 5 bottles per customer. Should you need more, please contact our office.

Sign Up now for Promotions and Updates >>>